Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7903 | 1315 | 36.3 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1155 | 2 | PEPT1//ORGANIC CATION TRANSPORTER//OATP1B1 | 9490 |
7903 | 1 | PEPT1//PEPT2//PEPTIDE TRANSPORTER | 1315 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEPT1 | authKW | 2201386 | 10% | 72% | 131 |
2 | PEPT2 | authKW | 1109940 | 4% | 89% | 54 |
3 | PEPTIDE TRANSPORTER | authKW | 1036260 | 6% | 55% | 81 |
4 | HPEPT1 | authKW | 722444 | 3% | 94% | 33 |
5 | OLIGOPEPTIDE TRANSPORTER | authKW | 454105 | 2% | 67% | 29 |
6 | GLYCYLSARCOSINE | authKW | 416217 | 2% | 81% | 22 |
7 | PEPTIDE TRANSPORT | authKW | 410770 | 4% | 35% | 51 |
8 | SLC15A1 | authKW | 358233 | 1% | 86% | 18 |
9 | MOL NUTR UNIT | address | 249869 | 4% | 20% | 55 |
10 | UPJOHN CLIN PHARMACOL | address | 227954 | 1% | 55% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 7505 | 44% | 0% | 584 |
2 | Physiology | 1560 | 13% | 0% | 166 |
3 | Biochemistry & Molecular Biology | 914 | 25% | 0% | 330 |
4 | Biophysics | 802 | 10% | 0% | 130 |
5 | Chemistry, Medicinal | 444 | 6% | 0% | 81 |
6 | Chemistry, Multidisciplinary | 205 | 11% | 0% | 145 |
7 | Gastroenterology & Hepatology | 205 | 5% | 0% | 60 |
8 | Medicine, Research & Experimental | 195 | 6% | 0% | 75 |
9 | Nutrition & Dietetics | 124 | 3% | 0% | 42 |
10 | Cell Biology | 47 | 5% | 0% | 69 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL NUTR UNIT | 249869 | 4% | 20% | 55 |
2 | UPJOHN CLIN PHARMACOL | 227954 | 1% | 55% | 18 |
3 | DRUG RAT | 211081 | 1% | 91% | 10 |
4 | UPJOHN 4302A | 96745 | 0% | 83% | 5 |
5 | MEMBRANE TRANSPORT GRP | 73631 | 2% | 15% | 21 |
6 | UPJOHN CLIN PHARMACOL 4302A | 69657 | 0% | 100% | 3 |
7 | PROV PHARMACOKINET TRANSPORT | 51231 | 1% | 28% | 8 |
8 | PHARMSAKYO KU | 32980 | 1% | 16% | 9 |
9 | EPITHELIAL GRP | 31604 | 1% | 17% | 8 |
10 | EXPLORATORY BIOPHARMACEUT STABIL | 26118 | 0% | 38% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUTICAL RESEARCH | 18522 | 6% | 1% | 80 |
2 | MOLECULAR PHARMACEUTICS | 7043 | 2% | 1% | 31 |
3 | AAPS PHARMSCI | 6488 | 1% | 4% | 7 |
4 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 5134 | 2% | 1% | 28 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 4254 | 3% | 1% | 34 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 3894 | 5% | 0% | 60 |
7 | JOURNAL OF PHARMACOBIO-DYNAMICS | 3181 | 1% | 1% | 15 |
8 | JOURNAL OF PHARMACEUTICAL SCIENCES | 3096 | 3% | 0% | 39 |
9 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 2925 | 2% | 0% | 32 |
10 | DRUG METABOLISM AND DISPOSITION | 2212 | 2% | 0% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEPT1 | 2201386 | 10% | 72% | 131 | Search PEPT1 | Search PEPT1 |
2 | PEPT2 | 1109940 | 4% | 89% | 54 | Search PEPT2 | Search PEPT2 |
3 | PEPTIDE TRANSPORTER | 1036260 | 6% | 55% | 81 | Search PEPTIDE+TRANSPORTER | Search PEPTIDE+TRANSPORTER |
4 | HPEPT1 | 722444 | 3% | 94% | 33 | Search HPEPT1 | Search HPEPT1 |
5 | OLIGOPEPTIDE TRANSPORTER | 454105 | 2% | 67% | 29 | Search OLIGOPEPTIDE+TRANSPORTER | Search OLIGOPEPTIDE+TRANSPORTER |
6 | GLYCYLSARCOSINE | 416217 | 2% | 81% | 22 | Search GLYCYLSARCOSINE | Search GLYCYLSARCOSINE |
7 | PEPTIDE TRANSPORT | 410770 | 4% | 35% | 51 | Search PEPTIDE+TRANSPORT | Search PEPTIDE+TRANSPORT |
8 | SLC15A1 | 358233 | 1% | 86% | 18 | Search SLC15A1 | Search SLC15A1 |
9 | PEPTIDE TRANSPORTER 1 | 206520 | 1% | 68% | 13 | Search PEPTIDE+TRANSPORTER+1 | Search PEPTIDE+TRANSPORTER+1 |
10 | GLY SAR | 178604 | 1% | 77% | 10 | Search GLY+SAR | Search GLY+SAR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRANDSCH, M , KNUTTER, I , BOSSE-DOENECKE, E , (2008) PHARMACEUTICAL AND PHARMACOLOGICAL IMPORTANCE OF PEPTIDE TRANSPORTERS.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 60. ISSUE 5. P. 543-585 | 218 | 85% | 95 |
2 | RUBIO-ALIAGA, I , DANIEL, H , (2008) PEPTIDE TRANSPORTERS AND THEIR ROLES IN PHYSIOLOGICAL PROCESSES AND DRUG DISPOSITION.XENOBIOTICA. VOL. 38. ISSUE 7-8. P. 1022 -1042 | 121 | 91% | 100 |
3 | SMITH, DE , CLEMENCON, B , HEDIGER, MA , (2013) PROTON-COUPLED OLIGOPEPTIDE TRANSPORTER FAMILY SLC15: PHYSIOLOGICAL, PHARMACOLOGICAL AND PATHOLOGICAL IMPLICATIONS.MOLECULAR ASPECTS OF MEDICINE. VOL. 34. ISSUE 2-3. P. 323-336 | 98 | 87% | 46 |
4 | NIELSEN, CU , BRODIN, B , JORGENSEN, FS , FROKJAER, S , STEFFANSEN, B , (2002) HUMAN PEPTIDE TRANSPORTERS: THERAPEUTIC APPLICATIONS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 12. ISSUE 9. P. 1329-1350 | 145 | 90% | 25 |
5 | BRANDSCH, M , (2009) TRANSPORT OF DRUGS BY PROTON-COUPLED PEPTIDE TRANSPORTERS: PEARLS AND PITFALLS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 8. P. 887 -905 | 94 | 99% | 45 |
6 | TERADA, T , INUI, K , (2004) PEPTIDE TRANSPORTERS: STRUCTURE, FUNCTION, REGULATION AND APPLICATION FOR DRUG DELIVERY.CURRENT DRUG METABOLISM. VOL. 5. ISSUE 1. P. 85-94 | 109 | 90% | 89 |
7 | BRODIN, B , NIELSEN, CU , STEFFANSEN, B , FROKJAER, S , (2002) TRANSPORT OF PEPTIDOMIMETIC DRUGS BY THE INTESTINAL DI/TRI-PEPTIDE TRANSPORTER, PEPT1.PHARMACOLOGY & TOXICOLOGY. VOL. 90. ISSUE 6. P. 285 -296 | 113 | 97% | 57 |
8 | HERRERA-RUIZ, D , KNIPP, GT , (2003) CURRENT PERSPECTIVES ON ESTABLISHED AND PUTATIVE MAMMALIAN OLIGOPEPTIDE TRANSPORTERS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 92. ISSUE 4. P. 691-714 | 121 | 83% | 72 |
9 | MEREDITH, D , BOYD, CAR , (2000) STRUCTURE AND FUNCTION OF EUKARYOTIC PEPTIDE TRANSPORTERS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 57. ISSUE 5. P. 754 -778 | 124 | 83% | 82 |
10 | BIEGEL, A , KNUTTER, I , HARTRODT, B , GEBAUER, S , THEIS, S , LUCKNER, P , KOTTRA, G , RASTETTER, M , ZEBISCH, K , THONDORF, I , ET AL (2006) THE RENAL TYPE H+/PEPTIDE SYMPORTER PEPT2: STRUCTURE-AFFINITY RELATIONSHIPS.AMINO ACIDS. VOL. 31. ISSUE 2. P. 137-156 | 87 | 98% | 53 |
Classes with closest relation at Level 1 |